TRIPLE-NEGATIVE BREAST CANCER (TNBC)

Clinical trials for TRIPLE-NEGATIVE BREAST CANCER (TNBC) explained in plain language.

Never miss a new study

Get alerted when new TRIPLE-NEGATIVE BREAST CANCER (TNBC) trials appear

Sign up with your email to follow new studies for TRIPLE-NEGATIVE BREAST CANCER (TNBC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 24 Not yet recruiting 12 Not yet finished but already full! 7 Terminated 1

Radioactive drug trial for advanced cancers halted early

Disease control Terminated

This study tested a new radioactive drug, [225Ac]-FPI-1434, in people with advanced solid tumors that had stopped responding to standard treatments. The goal was to check safety and find the right dose. The study was terminated early, so results are limited. It involved 78 partic…

Matched conditions: TRIPLE-NEGATIVE BREAST CANCER (TNBC)

Phase: PHASE1 • Sponsor: Fusion Pharmaceuticals Inc. • Aim: Disease control

Last updated May 17, 2026 01:03 UTC

TRIPLE-NEGATIVE BREAST CANCER (TNBC)

Get alerted when new TRIPLE-NEGATIVE BREAST CANCER (TNBC) trials appear

Radioactive drug trial for advanced cancers halted early